Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Prices of SAU stocks are not being updated. The latest Middle East Pharmaceutical Industries Company SJSC price on Alpha Spread is from Aug 7, 2024. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
|
SA |
|
EF On Inc
TSE:9514
|
JP |
|
R
|
Ramky Infrastructure Ltd
BSE:533262
|
IN |
|
Prada SpA
F:PRP
|
IT |
|
M
|
MYMBN Bhd
KLSE:MBN
|
MY |
|
I
|
Integrated Rail and Resources Acquisition Corp
F:5A3
|
US |
Intrinsic Value
Is Middle East Pharmaceutical Industries Company SJSC undervalued or overvalued?
See the intrinsic value estimate for Middle East Pharmaceutical Industries Company SJSC and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Middle East Pharmaceutical Industries Company SJSC Does
Middle East Pharmaceutical Industries Co. engages in the development, manufacture, marketing, and distribution of a wide range of generic medicines and pharmaceuticals. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2024-02-27. The firm develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of…
- Headquarters
- Saudi Arabia SA
- Employees
- 335
- IPO date
- Feb 27, 2024
Earnings Waterfall
Middle East Pharmaceutical Industries Company SJSC
The intrinsic value for Middle East Pharmaceutical Industries Company SJSC (4016) under the Base Case is hidden SAR.
Compared with the last price of 121.2 SAR on Aug 7, the stock appears hidden.